Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Evogene Ltd (NASDAQ:EVGN)

5.17
Delayed Data
As of 2:28pm ET
 -0.01 / -0.19%
Today’s Change
4.86
Today|||52-Week Range
8.06
+1.37%
Year-to-Date
No recent news for Evogene Ltd.

Today’s Trading

Previous close5.18
Today’s open5.18
Day’s range5.14 - 5.21
Volume4,900
Average volume (3 months)13,770
Market cap$132.1M
Dividend yield--
Data as of 2:28pm ET, 03/23/2017

Growth & Valuation

Earnings growth (last year)-13.24%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-41.23%
P/E ratio--
Price/Sales19.84
Price/Book1.51

Competitors

 Today’s
change
Today’s
% change
PFNXPfenex Inc-0.13-2.27%
NVIVInVivo Therapeutics ...+0.05+1.25%
VBLTVascular Biogenics L...+1.05+23.33%
QUREUniqure NV+0.02+0.35%
Data as of 4:02pm ET, 03/23/2017

Financials

Next reporting dateMay 10, 2017
EPS forecast (this quarter)-$0.18
Annual revenue (last year)$6.5M
Annual profit (last year)-$19.6M
Net profit margin-299.57%

Profile

Sector
Health Technology
Industry
Biotechnology
President &
Chief Executive Officer
Ofer Haviv
Chief Operating Officer
Yuval Ben-Galim
Corporate headquarters
Rehovot, Tel Aviv

Forecasts


Search for Jobs